Q3 confirmed three themes shaping healthcare M&A. First, innovation-anchored categories (Life Sciences and Digital Health) continue to command the largest share of transactions, with buyers favoring assets that advance precision medicine, data liquidity, and operational efficiency. Second, physician practice consolidation is entering a new phase characterized by disciplined platform building, selective large-cap moves, and an active add-on pipeline, along with some notable “second bites”. Third, health systems and large strategic buyers are leveraging M&A to rationalize portfolios and deepen capabilities where they maintain scale advantages, as evidenced by the quarter’s system divestitures and targeted acquisitions.
Read the full article: Healthcare M&A Insights for Q3 2025 //
Source: https://www.modernhealthcare.com/providers/mh-healthcare-ma-insights-q3/